Meiji Yasuda Life Insurance CO United Therapeutics Corp Transaction History

Meiji Yasuda Life Insurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $185,053 - $293,930	-2,433 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$107.15 - $126.84 $126,329 - $149,544	-1,179 Reduced 32.64%	2,433 $286,000
Q4 2018 Feb 12, 2019	SELL	$101.4 - $128.73 $79,903 - $101,439	-788 Reduced 17.91%	3,612 $393,000
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $71,700 - $81,559	630 Added 16.71%	4,400 $563,000
Q2 2018 Aug 13, 2018	BUY	$101.14 - $118.31 $23,262 - $27,211	230 Added 6.5%	3,770 $427,000
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $24,658 - $34,946	-230 Reduced 6.1%	3,540 $398,000
Q4 2017 Feb 13, 2018	BUY	$118.58 - $151.28 $226,487 - $288,944	1,910 Added 102.69%	3,770 $558,000
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $213,156 - $254,466	1,860	1,860 $218,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.